EE9900588A - CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral - Google Patents

CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral

Info

Publication number
EE9900588A
EE9900588A EEP199900588A EEP9900588A EE9900588A EE 9900588 A EE9900588 A EE 9900588A EE P199900588 A EEP199900588 A EE P199900588A EE P9900588 A EEP9900588 A EE P9900588A EE 9900588 A EE9900588 A EE 9900588A
Authority
EE
Estonia
Prior art keywords
graft
compositions
methods
blockade
insulin
Prior art date
Application number
EEP199900588A
Other languages
English (en)
Inventor
S. Kenyon Norma
Ricordi Camillo
W. Thomas David
Burkly Linda
Original Assignee
Biogen, Incorporated
University Of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Incorporated, University Of Miami filed Critical Biogen, Incorporated
Publication of EE9900588A publication Critical patent/EE9900588A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
EEP199900588A 1997-06-20 1998-06-19 CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral EE9900588A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5026797P 1997-06-20 1997-06-20
US7726598P 1998-03-09 1998-03-09
PCT/US1998/012892 WO1998058669A2 (en) 1997-06-20 1998-06-19 Cd154 blockade therapy for pancreatic islet tissue transplantation

Publications (1)

Publication Number Publication Date
EE9900588A true EE9900588A (et) 2000-08-15

Family

ID=26728084

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900588A EE9900588A (et) 1997-06-20 1998-06-19 CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral

Country Status (22)

Country Link
US (2) US20030072754A1 (et)
EP (1) EP1051191B1 (et)
JP (1) JP2002506446A (et)
KR (1) KR100634847B1 (et)
CN (2) CN1651919A (et)
AT (1) ATE339966T1 (et)
AU (1) AU730763B2 (et)
BG (1) BG64976B1 (et)
BR (1) BR9810620A (et)
CA (1) CA2294154A1 (et)
DE (1) DE69835965T2 (et)
EA (1) EA002550B1 (et)
EE (1) EE9900588A (et)
HK (1) HK1033548A1 (et)
HU (1) HUP0003160A3 (et)
IL (1) IL133303A0 (et)
IS (1) IS5273A (et)
NO (1) NO996275L (et)
NZ (1) NZ502052A (et)
SK (1) SK180299A3 (et)
TR (1) TR199903142T2 (et)
WO (1) WO1998058669A2 (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045958A1 (en) * 1998-03-09 1999-09-16 Biogen, Inc. Cd154 blockade therapy for modulation of immune responses to implanted devices
AU2001251612A1 (en) 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
EP1289554A4 (en) * 2000-06-02 2004-05-26 Univ Minnesota IMMUNOTHERAPEUTIC PROCESS FOR PREVENTING REJECTION OF ISLAND CELLS
CA2411962A1 (en) * 2000-06-09 2001-12-20 Bristol-Myers Squibb Company Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
AU2004253868B2 (en) * 2003-06-13 2011-06-16 Biogen Ma Inc. Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof
WO2006033702A2 (en) 2004-07-26 2006-03-30 Biogen Idec Ma Inc. Anti-cd154 antibodies
JP2008520235A (ja) * 2004-11-22 2008-06-19 ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド インスリンを産生可能な拡大され、かつ再分化した成体島β細胞の集団およびその作製方法
WO2007047539A2 (en) * 2005-10-14 2007-04-26 Medtronic, Inc. Localized delivery to the lymphatic system
US8372399B2 (en) 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US8636995B2 (en) 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
US8911739B2 (en) 2009-02-10 2014-12-16 Trustees Of Columbia University In The City Of New York Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
US9527912B2 (en) 2010-05-17 2016-12-27 The Board Of Trustees Of The Leland Stanford Junior University Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
US9512229B2 (en) 2015-03-03 2016-12-06 Kymab Limited Synergistic combinations of OX40L antibodies for the treatment of GVHD
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
US10986309B2 (en) 2015-06-30 2021-04-20 Nxp Usa, Inc. Video buffering and frame rate doubling device and method
WO2018083248A1 (en) 2016-11-03 2018-05-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5474771A (en) * 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5683693A (en) * 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
EP0892643B2 (en) * 1996-03-20 2009-09-02 Bristol-Myers Squibb Company Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith

Also Published As

Publication number Publication date
HUP0003160A3 (en) 2002-09-30
EP1051191A2 (en) 2000-11-15
DE69835965D1 (de) 2006-11-02
AU7983098A (en) 1999-01-04
NO996275D0 (no) 1999-12-17
HK1033548A1 (en) 2001-09-07
DE69835965T2 (de) 2007-06-14
CN1651919A (zh) 2005-08-10
CN1195546C (zh) 2005-04-06
EA002550B1 (ru) 2002-06-27
SK180299A3 (en) 2000-06-12
IS5273A (is) 1999-11-26
JP2002506446A (ja) 2002-02-26
AU730763B2 (en) 2001-03-15
KR100634847B1 (ko) 2006-10-17
BG104091A (en) 2000-10-31
CN1261286A (zh) 2000-07-26
WO1998058669A2 (en) 1998-12-30
NO996275L (no) 2000-02-21
US20070292440A1 (en) 2007-12-20
IL133303A0 (en) 2001-04-30
HUP0003160A2 (hu) 2001-01-29
BR9810620A (pt) 2000-10-03
BG64976B1 (bg) 2006-11-30
NZ502052A (en) 2001-01-26
KR20010013965A (ko) 2001-02-26
EA200000058A1 (ru) 2000-08-28
ATE339966T1 (de) 2006-10-15
EP1051191B1 (en) 2006-09-20
US20030072754A1 (en) 2003-04-17
CA2294154A1 (en) 1998-12-30
TR199903142T2 (xx) 2000-09-21
WO1998058669A3 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
EE9900588A (et) CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral
ATE482717T1 (de) Peptid yy (pyy) zur behandlung von glukose stoffwechselkrankheiten
EP1220611A4 (en) SUPPRESSOR CELLS FOR THE PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATIONS
DK1066052T3 (da) Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer
WO2003102162A3 (en) Novel tolerogenic dendritic cells and therapeutic uses therefor
IL95046A0 (en) Substituted 2-imidazolines and pharmaceutical compositions containing them
GR3022672T3 (en) Use of ifn-gamma for the treatment of infections in transplant recipients.
EP1754490A3 (en) CD 154 blockage therapy for pancreatic islet tissue transplantation in primates
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
UA32295A (uk) Спосіб лікування порушень фертильності у хворих на цукровий діабет
EP0886528A4 (en) USE OF COXIELLA BACTERIA TO TREAT AUTOIMMUNE DISEASES
WO2001051093A3 (en) METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS
DK1370641T3 (da) Anvendelse af stamceller og CD6-depleterede stamceller til toleransinduktion i forhold til allogene transplantater og/eller leukæmibehandling
CA2402489A1 (en) Oral tolerance induction by collagen to prevent allograft rejection
NO20016326L (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
NO950114L (no) Amylin-antagonister og agonister
ATE283063T1 (de) Allogene und xenogene transplantation
UA39046A (uk) Спосіб лікування інсулінозалежного цукрового діабету
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC1A Change of owner name